Female patient using a pre-filled pen to inject herself with Semaglutide diabetes medication. Marketed as Ozempic, this is a glucagon-like peptide-1 (GLP-1) analogue that is used to treat diabetes and is used for weight management. It increases the production of insulin, the hormone that lowers blood sugar levels, while also suppressing secretion of glucagon, the hormone that raises blood sugar levels. It also reduces hunger and slows gastric emptying. Ozempic is administered by injection into the thigh, abdomen or upper arm. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library |
Bildgröße: | 8256 px × 5504 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: |
|